Hood River Capital Management »

BioCryst Pharmaceuticals shares owned by Hood River Capital Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Hood River Capital Management from 13F filings

Historical chart of Hood River Capital Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Hood River Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Hood River Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $28M 3.6M 7.59
2025-06-30 $11M 1.2M 8.96

More positions owned by Hood River Capital Management

Applied Digital Corp Common Stocks (APLD)
Mastec Common Stocks (MTZ)
Kratos Defense & Security Common Stocks (KTOS)
Dave Common Stocks (DAVE)
Comfort Systems Usa Common Stocks (FIX)
Ciena Corp Common Stocks (CIEN)
Aci Worldwide Common Stocks (ACIW)
Semtech Corp Common Stocks (SMTC)
Qxo Common Stocks (QXO)
Xpo Common Stocks (XPO)
Hci Group Common Stocks (HCI)
Sitime Corp Common Stocks (SITM)
Ollies Bargain Outlet Hldg Common Stocks (OLLI)
Firstcash Holdings Common Stocks (FCFS)
Insmed Common Stocks (INSM)

View all positions for Hood River Capital Management

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
BlackRock
Deerfield Management Company
State Street Corporation
Kynam Capital Management
UBS Group
Alkeon Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Hood River Capital Management
Nuveen
Assenagon Asset Management

View all funds holding BioCryst Pharmaceuticals